Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011)

Therapeutic Apheresis and Dialysis

Volumn 17, Issue 6, 2013, Pages 567-611

  Nakai, Shigeru ^a   Watanabe, Yuzo ^a   Masakane, Ikuto ^a   Wada, Atsushi ^a   Shoji, Tetsuo ^a   Hasegawa, Takeshi ^a   Nakamoto, Hidetomo ^a   Yamagata, Kunihiro ^a   Kazama, Junichiro James ^a   Fujii, Naohiko ^a   Itami, Noritomo ^a   Shinoda, Toshio ^a   Shigematsu, Takashi ^a   Marubayashi, Seiji ^a   Morita, Osamu ^a   Hashimoto, Seiji ^a   Suzuki, Kazuyuki ^a   Kimata, Naoki ^a   Hanafusa, Norio ^a   Wakai, Kenji ^a   Hamano, Takayuki ^a   Ogata, Satoshi ^a   Tsuchida, Kenji ^a   Taniguchi, Masatomo ^a   Nishi, Hiroshi ^a   Iseki, Kunitoshi ^a   Tsubakihara, Yoshiharu ^a   more..

^a Scientific Academic Committee of the Japanese Society for Dialysis Therapy   (Japan)

Author keywords

Combined use; Dialysis patient population; Peritoneal dialysis; Survival rate; Uric acid

Indexed keywords

ALBUMIN; ALLOPURINOL; ANTILIPEMIC AGENT; BENZBROMARONE; CHOLESTEROL; CITRATE POTASSIUM SODIUM; ENDOTOXIN; FEBUXOSTAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UREA; URIC ACID;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BACTERIAL COUNT; BODY MASS; CATABOLISM; CAUSE OF DEATH; CHILD; CHOLESTEROL BLOOD LEVEL; CHRONIC GLOMERULONEPHRITIS; DIABETIC NEPHROPATHY; DIALYSATE; DIALYSIS; FEMALE; GOUT; HEART INFARCTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERURICEMIA; JAPAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS CATHETER; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL RATE; URIC ACID BLOOD LEVEL;

COMBINED USE; DIALYSIS PATIENT POPULATION; PERITONEAL DIALYSIS; SURVIVAL RATE; URIC ACID;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH SURVEYS; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; QUESTIONNAIRES; RENAL DIALYSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84890186642     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12147     Document Type: Article

References (10)

1. Nakai S. The history of Japanese Society for Dialysis Therapy Registry. J Jpn Soc Dial Ther 2010;43:119-152.
2. Nakai S, Iseki K, Itami N etal. An overview of regular dialysis treatment in Japan (as of 31 December 2010). Ther Apher Dial 2012;16:483-521.
3. Committee of Renal Data Registry, Japanese Society for Dialysis Therapy. An Overview of Regular Dialysis Treatment in Japan. Tokyo, 2013. [Accessed Oct 2013.] Available from URL: http://docs.jsdt.or.jp/overview/index.html.
4. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chron Dis 1958;8:699-712.
5. Nakai S, Wakai K, Yamagata K, Iseki K, Tsubakihara Y. Prediction of dialysis patients in Japan: based on Japanese Society for Dialysis Therapy Registry. J Jpn Soc Dial Ther 2012;45:599-613.
6. United States Renal Data System. USRDS Annual Data Report-VolumeTwo-Atlas of End-Stage Renal Disease in the United States. Minneapolis, MN: National Institutes of Health, 2011.
7. Shinzato T, Nakai S, Fujita Y etal. Determination of Kt/V and protein catabolic rate using pre- and postdialysis blood urea nitrogen concentrations. Nephron 1994;67:280-290.
8. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4:1205-1213.
9. Kawanishi H, Akiba T, Masakane I etal. Standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy 2008. Ther Apher Dial 2009;13:161-166.
10. Nakai S, Iseki K, Itami N etal. Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial 2012;16:11-53.